Opdivo Improves Disease-Free Survival in Skin Cancer Subtype 🔗 Access full article via CureTodayPatients with advanced Merkel cell carcinoma treated with Opdivo had improved disease-free survival rates compared with those who underwent observation. Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon